Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
Australia
/
Healthcare
/
Nanosonics
Create a narrative
Nanosonics Community
ASX:NAN Community
3
Narratives
written by author
1
Comments
on narratives written by author
41
Fair Values set
on narratives written by author
Community Investing Ideas
Nanosonics
Popular
Undervalued
Overvalued
Nanosonics
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Rising Global Aging And Regulatory Demands Will Accelerate Automated Disinfection
Key Takeaways Accelerated adoption, regulatory shifts, and digital innovations could drive recurring revenue and margin growth far ahead of current analyst expectations. Strategic manufacturing integration and potential acquisitions may rapidly expand market reach, cost advantages, and diversification within infection prevention.
View narrative
AU$6.18
FV
32.7% undervalued
intrinsic discount
13.80%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Nanosonics
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Automated Disinfection Solutions Will Transform Hospital Safety Worldwide
Key Takeaways Expansion of automated disinfection solutions and next-generation product launches are driving adoption, recurring revenue, and higher margins globally. Scalable operations and investment in innovation position the company for sustained earnings and margin growth as its product and geographic footprint expands.
View narrative
AU$4.75
FV
12.4% undervalued
intrinsic discount
9.85%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
23
users have followed this narrative
16 days ago
author updated this narrative
Nanosonics
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Rising Hospital Cost Containment And Tech Obsolescence Will Erode Profitability
Key Takeaways Dependence on a single premium product and increased competition from emerging disinfection technologies threaten revenue growth and pricing power. Rising compliance costs, stronger customer bargaining power, and unfavorable currency movements risk compressing margins and hindering global expansion.
View narrative
AU$3.9
FV
6.7% overvalued
intrinsic discount
6.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
17 days ago
author updated this narrative